Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies

Transplantation

Volumn 63, Issue 9, 1997, Pages 1355-1358

  Auersvald, Luiz A ^a   Rothstein, David M ^a   Oliveira, Sergio C ^a   Khuong, Chau Q ^a   Onodera, Hideo ^b   Lazarovits, Andrew I ^c   Basadonna, Giacomo P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C363 16A; MONOCLONAL ANTIBODY MB2362; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRAFT SURVIVAL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD45; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031007024     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00026     Document Type: Article

References (28)

1. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977.
3. Weber C, Silva F, Hardy M, Pirani C, Reemtsma K. Islet transplants and nephropathy. In: Friedman E, L'Esperance F, eds. Diabetic renal-retinal syndrome. New York: Grune & Stratton, 1980: 373.
4. Barker CF, Naji A. Perspectives in pancreatic and islet transplantation. N Engl J Med 1992; 327: 271.
5. Robertson RP. Seminars in medicine of the Beth Israel Hospital, Boston: pancreatic and islet transplantation for diabetes - cures or curiosities? N Engl J Med 1992; 327: 1861.
6. Sabiston, Jr., ed. The Sabiston textbook of surgery: the biological basis of surgical practice, 13th ed. Philadelphia: Saunders, 1986: 469.
7. Najarian JS, Sutherland DER, Matas AJ, Steffes MW, Simmons RL, Goetz FC. Human islet transplantation: a preliminary report. Transplant Proc 1977; 9: 233.
8. Pyzdrowski KL, Kendall DM, Halter JB, Nakhleh RE, Sutherland DE, Robertson RP. Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med 1992; 327: 220.
9. Hering BJ, Bretzel RG, Federlin K. Current status of clinical islet transplantation. Horm Metab Res 1988; 20: 537.
10. Ricordi C, Tzakis A, Alejandro R, et al. Detection of pancreatic islet tissue following islet allotransplantation in man. Transplantation 1991; 52: 1079.
11. Gores PF, Najarian JS, Stephanian E, Lloveras JJ, Kelley SL, Sutherland DE. Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 1993; 341: 19.
12. Trowbridge IS. CD45: a prototype for transmembrane protein tyrosine phosphatases. J Biol Chem 1991; 266: 23517.
13. Pingel JT, Thomas ML. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 1989; 58: 1055.
14. Koretzky GA, Picus J, Thomas ML, Weiss A. Tyronine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 1990; 346: 66.
15. Ostergaard HL, Shackelford DA, Hurley TR, et al. Expression of CD45 alters phosphorylation of the lck encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci USA. 1989; 86: 8959.
16. Streuli M, Hall LR, Saga Y, Schlossman SF, Saito H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med 1987; 166: 1548.
17. Bottomly K, Luqman M, Greenbaum L, et al. A monoclonal antibody to murine CD45R distinguishes T cell populations that produce different cytokines. Eur J Immunol 1989; 19: 617.
18. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 1985; 40: 437.
19. Nakayama E. Blocking of effector cell cytotoxicity and T-cell proliferation by Lyt antisera. Immunol Rev 1982; 68: 117.
20. Lefrancois L, Bevan MJ. Novel antigenic determinants of the T200 glycoprotein expressed preferentially by activated cytotoxic T lymphocytes. J Immunol 1985; 135: 374.
21. Takeuchi T, Rudd CE, Scholssman SF, Morimoto C. Induction of suppression following autologous mixed lymphocyte reaction: role of a novel 2H4 antigen. Eur J Immunol 1987; 17: 97.
22. Harp JA, Ewald SJ. Modulation of in vitro immune responses by monoclonal antibody to T200 antigen. Cell Immunol 1983; 81: 71.
23. Lazarovits AI, Poppema S, White MJ, Karsh J. Inhibition of alloreactivity in vitro by monoclonal antibodies directed against restricted isoforms of the leukocyte-common antigen (CD45). Transplantation 54: 724.
24. Prickett TC, Hart DN. Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation. Immunology 1990; 69: 250.
25. Lazarovits AI, Poppema S, Zhang Z, et al. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 1996; 380: 717.
26. McKenney D, Onodera H, Gorman L, Mimura T, Rothstein DM. Distinct isoforms of the CD45 protein tyrosine phosphatase differentially regulate IL-2 secretion and activation signal pathways involving vav in T cells. J Biol Chem 1995; 270: 24949.
27. Onodera H, Motto D, Koretzky G, Rothstein DM. Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP-76 to vav by distinct isoforms of the CD45 protein tyrosine phosphatase. J Biol Chem 1996; 271: 22225.
28. Thomas ML. The leukocyte common antigen family. Annu Rev Immunol 1994; 12: 85.